Evidence map›Paper›PMID 38022092›Full record

ArticleCureus2023

ChatGPT's Epoch in Rheumatological Diagnostics: A Critical Assessment in the Context of Sjögren's Syndrome.

Bilal Irfan, Aneela Yaqoob

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bilal IrfanMicrobiology and Immunology, University of Michigan, Ann Arbor, USA.
Aneela YaqoobInfectious Diseases, Beaumont Hospital, Taylor, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe rise of artificial intelligence in medical practice is reshaping clinical care. Large language models (LLMs) like ChatGPT have the potential to assist in rheumatology by personalizing scientific information retrieval, particularly in the context of Sjögren's Syndrome. This study aimed to evaluate the efficacy of ChatGPT in providing insights into Sjögren's Syndrome, differentiating it from other rheumatological conditions. MATERIALS AND

methodsA database of peer-reviewed articles and clinical guidelines focused on Sjögren's Syndrome was compiled. Clinically relevant questions were presented to ChatGPT, with responses assessed for accuracy, relevance, and comprehensiveness. Techniques such as blinding, random control queries, and temporal analysis ensured unbiased evaluation. ChatGPT's responses were also assessed using the 15-questionnaire DISCERN tool.

resultsChatGPT effectively highlighted key immunopathological and histopathological characteristics of Sjögren's Syndrome, though some crucial data and citation inconsistencies were noted. For a given clinical vignette, ChatGPT correctly identified potential etiological considerations with Sjögren's Syndrome being prominent. DISCUSSION: LLMs like ChatGPT offer rapid access to vast amounts of data, beneficial for both patients and providers. While it democratizes information, limitations like potential oversimplification and reference inaccuracies were observed. The balance between LLM insights and clinical judgment, as well as continuous model refinement, is crucial.

conclusionLLMs like ChatGPT offer significant potential in rheumatology, providing swift and broad medical insights. However, a cautious approach is vital, ensuring rigorous training and ethical application for optimal patient care and clinical practice.

Indexed as

artificial intelligence (ai)chatgptchatgpt-4large language models (llms)sjögren’s syndrome

Identifiers

PMID38022092
PMCPMC10676288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.